Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI (2002) J Clin Endocrinol Metab 87: 4297-300 Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. Colilla S, Cox NJ, Ehrmann DA (2001) J Clin Endocrinol Metab 86: 2027-31 Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA (2002) J Clin Endocrinol Metab 87: 772-5 Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. Ehrmann DA, Schwarz PE, Hara M, Tang X, Horikawa Y, Imperial J, Bell GI, Cox NJ (2002) J Clin Endocrinol Metab 87: 1669-73 Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. Haddad L, Evans JC, Gharani N, Robertson C, Rush K, Wiltshire S, Frayling TM, Wilkin TJ, Demaine A, Millward A, Hattersley AT, Conway G, Cox NJ, Bell GI, Franks S, McCarthy MI (2002) J Clin Endocrinol Metab 87: 2606-10 Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K (2011) Obstet Gynecol 117: 6-13 Alterations in carbohydrate metabolism as they apply to reproductive endocrinology. Diamond MP, Wentz AC, Cherrington AD (1988) Fertil Steril 50: 387-97 Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ, STRAW + 10 Collaborative Group (2012) Fertil Steril 97: 843-51 Increased COMT expression in PCOS biology. Nair S, Al-Hendy A, Tamboli RA, Marks-Shulman PA, Abumrad NN (2012) Mol Cell Endocrinol 355: 188-9 Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice. Devin JK, Johnson JE, Eren M, Gleaves LA, Bradham WS, Bloodworth JR, Vaughan DE (2007) J Mol Endocrinol 39: 9-16 Optimizing natural fertility: the role of lifestyle modification. McLean M, Wellons MF (2012) Obstet Gynecol Clin North Am 39: 465-77 Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome. Moradi S, Mollabashi M, Kerman SR (2011) Gynecol Endocrinol 27: 480-5
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.